Authors:
COHEN ML
BLOOMQUIST W
CALLIGARO D
SWANSON S
Citation: Ml. Cohen et al., COMPARATIVE 5-HT4 RECEPTOR ANTAGONIST ACTIVITY OF LY353433 AND ITS ACTIVE HYDROXYLATED METABOLITES, Drug development research, 43(4), 1998, pp. 193-199
Authors:
COHEN ML
BLOOMQUIST W
SCHAUS JM
THOMPSON DC
SUSEMICHEL AD
CALLIGARO DO
COHEN I
Citation: Ml. Cohen et al., LY353433, A POTENT, ORALLY EFFECTIVE, LONG-ACTING 5-HT4 RECEPTOR ANTAGONIST - COMPARISON TO CISAPRIDE AND RS23597-190, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 97-104
Authors:
COHEN ML
SARAZAN RD
KLOTZ U
BLOOMQUIST W
PALKOWITZ A
Citation: Ml. Cohen et al., EFFECT OF BETA(3)-SELECTIVE AGONISTS, BRL-37,344 AND CL-316,243 ON BLOOD-PRESSURE AND HEART-RATE IN THE RAT, Journal of drug development and clinical practice, 7(1), 1995, pp. 37-44
Authors:
COHEN ML
SUSEMICHEL AD
BLOOMQUIST W
ROBERTSON DW
Citation: Ml. Cohen et al., 5-HT4 RECEPTORS IN RAT BUT NOT GUINEA-PIG, RABBIT OR DOG ESOPHAGEAL SMOOTH-MUSCLE, General pharmacology, 25(6), 1994, pp. 1143-1148
Citation: Ml. Cohen et W. Bloomquist, EFFECT OF 5-HT2 RECEPTOR ANTAGONIST ERGOLINES AND THEIR DESISOPROPYL METABOLITES ON RABBIT PLATELET-AGGREGATION IN-VITRO AND EX-VIVO, Drug development research, 32(3), 1994, pp. 153-160
Authors:
COHEN ML
BLOOMQUIST W
SCHMID CR
ROBERTSON DW
WONG DT
Citation: Ml. Cohen et al., ZATOSETRON, A SELECTIVE 5-HT(3)-RECEPTOR ANTAGONIST - PHARMACOLOGICALACTIVITIES OF HUMAN AND ANIMAL METABOLITES, Drug development research, 29(3), 1993, pp. 209-215
Authors:
MARTINELLI MJ
BLOOMQUIST W
PETERSON BC
COHEN ML
Citation: Mj. Martinelli et al., AMESERGIDE AND STRUCTURALLY RELATED NOR-D-ERGOLINES - 5HT(2) RECEPTORINTERACTIONS IN THE RAT, Journal of medicinal chemistry, 36(18), 1993, pp. 2671-2675